FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals

Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals, specifically, solid organ … Continue reading FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals